Chai Discovery, an AI drug-discovery startup, raises a $130 million Series B at a $1.3 billion valuation, with plans to build a “computer-aided design suite” for molecules. Chai Discovery co-founder Joshua Meier and investor Elena Viboch, managing director at General Catalyst, join Caroline Hyde on “Bloomberg Tech.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on…
X:
Facebook:
Instagram:
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
Listen to the daily Bloomberg Technology podcast here:
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:
source
